Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Rev Cardiol. 2012 Oct;9(10):605-9. doi: 10.1038/nrcardio.2012.108. Epub 2012 Aug 7.

The emerging role of amiodarone and dronedarone in Chagas disease.

Author information

  • 1Instituto de Estudios Avanzados (IDEA), Sartenejas, Baruta, Caracas 1080, Venezuela. gbenaim@idea.gob.ve

Abstract

Chagas disease has emerged as an important health problem in the Americas and, with globalization, in other parts of the world. Drug therapy for this parasitic infection has remained largely ineffective, especially in chronic stages of the disease. However, developments in experimental therapy might signal an important advance for the management of patients with Chagas disease. Herein, we review studies on the potential use of the benzofuran derivatives amiodarone and dronedarone in patients with Chagas disease. These agents have a dual role, not only as primary antiarrhythmic drugs, but also as antiparasitic agents. We believe that this 'kill two birds with one stone' approach represents a new tactic for the treatment of Chagas disease using currently approved drugs.

PMID:
22869282
DOI:
10.1038/nrcardio.2012.108
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center